Day One Biopharmaceuticals, Inc. (DAWN) Deferred Tax Assets, Valuation Allowance USD 2020 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Day One Biopharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2020 to 2023.
  • Day One Biopharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $94.4 M, a 75.4% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $94.4 M +$40.6 M +75.4% Dec 31, 2023 10-K 2024-02-26
Q4 2022 $53.8 M +$30 M +126% Dec 31, 2022 10-K 2024-02-26
Q4 2021 $23.8 M +$15.2 M +176% Dec 31, 2021 10-K 2024-02-26
Q4 2020 $8.6 M Dec 31, 2020 10-K 2024-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.